Skip to main content
Erschienen in: Supportive Care in Cancer 10/2019

12.02.2019 | Original Article

Exercise-based rehabilitation for cancer survivors with chemotherapy-induced peripheral neuropathy

verfasst von: J. Matt McCrary, David Goldstein, Carolina X. Sandler, Benjamin K. Barry, Michael Marthick, Hannah C. Timmins, Tiffany Li, Lisa Horvath, Peter Grimison, Susanna B. Park

Erschienen in: Supportive Care in Cancer | Ausgabe 10/2019

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Chemotherapy-induced peripheral neuropathy (CIPN) affects up to 40% of cancer survivors and is associated with functional deficits and an increased falls incidence. There are presently no strongly recommended treatment strategies for CIPN. The aim of this study was to evaluate the impact of a multimodal exercise intervention on CIPN symptoms and related functional deficits, as well as neurophysiologic parameters.

Methods

All outcomes were assessed before and after an 8-week exercise intervention (3-weekly sessions) and preceding 8-week control period at baseline, pre-exercise and post-exercise. Outcome measures were objective and patient-reported CIPN, standing and dynamic balance, mobility, quality of life, and sensory and motor nerve excitability and conduction studies.

Results

Twenty-nine cancer survivors (8 male, 21 female; mean age 61.6 ± 11.8 years) with CIPN symptoms affecting function completed all assessments. Objective and patient-reported CIPN, dynamic balance, standing balance in eyes open conditions, mobility and quality of life were improved from pre- to post-exercise (4.0 < F < 10.2; p < .05), with no changes over the control period (p > .21). No changes were observed in sensory or motor neurophysiologic parameters (p > .23).

Conclusions

This study provides encouraging evidence of the rehabilitative potential of multimodal exercise for persisting CIPN in a post-treatment cohort. Large randomised controlled trials are justified to confirm observed benefits and determine the mechanisms and clinical significance.
Literatur
1.
Zurück zum Zitat IARC (2014) (International Agency for Research on Cancer). World Cancer report. In. WHO Press, Geneva IARC (2014) (International Agency for Research on Cancer). World Cancer report. In. WHO Press, Geneva
2.
Zurück zum Zitat Park SB, Goldstein D, Krishnan AV, Lin CS, Friedlander ML, Cassidy J, Koltzenburg M, Kiernan MC (2013) Chemotherapy-induced peripheral neurotoxicity: a critical analysis. CA Cancer J Clin 63:419–437CrossRefPubMed Park SB, Goldstein D, Krishnan AV, Lin CS, Friedlander ML, Cassidy J, Koltzenburg M, Kiernan MC (2013) Chemotherapy-induced peripheral neurotoxicity: a critical analysis. CA Cancer J Clin 63:419–437CrossRefPubMed
3.
Zurück zum Zitat Seretny M, Currie GL, Sena ES, Ramnarine S, Grant R, MacLeod MR, Colvin LA, Fallon M (2014) Incidence, prevalence, and predictors of chemotherapy-induced peripheral neuropathy: a systematic review and meta-analysis. PAIN 155:2461–2470CrossRefPubMed Seretny M, Currie GL, Sena ES, Ramnarine S, Grant R, MacLeod MR, Colvin LA, Fallon M (2014) Incidence, prevalence, and predictors of chemotherapy-induced peripheral neuropathy: a systematic review and meta-analysis. PAIN 155:2461–2470CrossRefPubMed
4.
Zurück zum Zitat Wolf S, Barton D, Kottschade L, Grothey A, Loprinzi C (2008) Chemotherapy-induced peripheral neuropathy: prevention and treatment strategies. Eur J Cancer 44:1507–1515CrossRef Wolf S, Barton D, Kottschade L, Grothey A, Loprinzi C (2008) Chemotherapy-induced peripheral neuropathy: prevention and treatment strategies. Eur J Cancer 44:1507–1515CrossRef
5.
Zurück zum Zitat Mols F, Beijers T, Lemmens V et al (2013) Chemotherapy-induced neuropathy and its association with quality of life among 2-to 11-year colorectal cancer survivors: results from the population-based PROFILES registry. J Clin Oncol 31(21):2699–707 Mols F, Beijers T, Lemmens V et al (2013) Chemotherapy-induced neuropathy and its association with quality of life among 2-to 11-year colorectal cancer survivors: results from the population-based PROFILES registry. J Clin Oncol 31(21):2699–707
6.
Zurück zum Zitat Winters-Stone KM, Horak F, Jacobs PG et al (2017) Falls, functioning, and disability among women with persistent symptoms of chemotherapy-induced peripheral neuropathy. J Clin Oncol 35(23):2604–2612 Winters-Stone KM, Horak F, Jacobs PG et al (2017) Falls, functioning, and disability among women with persistent symptoms of chemotherapy-induced peripheral neuropathy. J Clin Oncol 35(23):2604–2612
7.
Zurück zum Zitat Hershman DL, Lacchetti C, Dworkin RH, Lavoie Smith EM, Bleeker J, Cavaletti G, Chauhan C, Gavin P, Lavino A, Lustberg MB, Paice J, Schneider B, Smith ML, Smith T, Terstriep S, Wagner-Johnston N, Bak K, Loprinzi CL, American Society of Clinical Oncology (2014) Prevention and management of chemotherapy-induced peripheral neuropathy in survivors of adult cancers: American Society of Clinical Oncology clinical practice guideline. J Clin Oncol 32:1941–1967CrossRefPubMed Hershman DL, Lacchetti C, Dworkin RH, Lavoie Smith EM, Bleeker J, Cavaletti G, Chauhan C, Gavin P, Lavino A, Lustberg MB, Paice J, Schneider B, Smith ML, Smith T, Terstriep S, Wagner-Johnston N, Bak K, Loprinzi CL, American Society of Clinical Oncology (2014) Prevention and management of chemotherapy-induced peripheral neuropathy in survivors of adult cancers: American Society of Clinical Oncology clinical practice guideline. J Clin Oncol 32:1941–1967CrossRefPubMed
8.
Zurück zum Zitat Zimmer P, Trebing S, Timmers-Trebing U et al (2017) Eight-week, multimodal exercise counteracts a progress of chemotherapy-induced peripheral neuropathy and improves balance and strength in metastasized colorectal cancer patients: a randomized controlled trial. Support Care Cancer:1–10 Zimmer P, Trebing S, Timmers-Trebing U et al (2017) Eight-week, multimodal exercise counteracts a progress of chemotherapy-induced peripheral neuropathy and improves balance and strength in metastasized colorectal cancer patients: a randomized controlled trial. Support Care Cancer:1–10
9.
Zurück zum Zitat Kleckner IR, Kamen C, Gewandter JS et al (2017) Effects of exercise during chemotherapy on chemotherapy-induced peripheral neuropathy: a multicenter, randomized controlled trial. Support Care Cancer:1–10 Kleckner IR, Kamen C, Gewandter JS et al (2017) Effects of exercise during chemotherapy on chemotherapy-induced peripheral neuropathy: a multicenter, randomized controlled trial. Support Care Cancer:1–10
10.
Zurück zum Zitat Streckmann F, Kneis S, Leifert J et al (2014) Exercise program improves therapy-related side-effects and quality of life in lymphoma patients undergoing therapy. Ann Oncol 25:493–499CrossRefPubMed Streckmann F, Kneis S, Leifert J et al (2014) Exercise program improves therapy-related side-effects and quality of life in lymphoma patients undergoing therapy. Ann Oncol 25:493–499CrossRefPubMed
11.
Zurück zum Zitat Vollmers PL, Mundhenke C, Maass N, Bauerschlag D, Kratzenstein S, Röcken C, Schmidt T (2018) Evaluation of the effects of sensorimotor exercise on physical and psychological parameters in breast cancer patients undergoing neurotoxic chemotherapy. J Cancer Res Clin Oncol 144:1785–1792CrossRefPubMed Vollmers PL, Mundhenke C, Maass N, Bauerschlag D, Kratzenstein S, Röcken C, Schmidt T (2018) Evaluation of the effects of sensorimotor exercise on physical and psychological parameters in breast cancer patients undergoing neurotoxic chemotherapy. J Cancer Res Clin Oncol 144:1785–1792CrossRefPubMed
12.
Zurück zum Zitat Schwenk M, Grewal GS, Holloway D, Muchna A, Garland L, Najafi B (2016) Interactive sensor-based balance training in older cancer patients with chemotherapy-induced peripheral neuropathy: a randomized controlled trial. Gerontology 62:553–563CrossRefPubMed Schwenk M, Grewal GS, Holloway D, Muchna A, Garland L, Najafi B (2016) Interactive sensor-based balance training in older cancer patients with chemotherapy-induced peripheral neuropathy: a randomized controlled trial. Gerontology 62:553–563CrossRefPubMed
13.
Zurück zum Zitat Fernandes J, Kumar S (2016) Effect of lower limb closed kinematic chain exercises on balance in patients with chemotherapy-induced peripheral neuropathy: a pilot study. Int J Rehabil Res 39:368–371CrossRefPubMed Fernandes J, Kumar S (2016) Effect of lower limb closed kinematic chain exercises on balance in patients with chemotherapy-induced peripheral neuropathy: a pilot study. Int J Rehabil Res 39:368–371CrossRefPubMed
14.
Zurück zum Zitat Wonders KY, Whisler G, Loy H, Holt B, Bohachek K, Wise R (2013) Ten weeks of home-based exercise attenuates symptoms of chemotherapy-induced peripheral neuropathy in breast cancer patients. Health Psychol Res 1 Wonders KY, Whisler G, Loy H, Holt B, Bohachek K, Wise R (2013) Ten weeks of home-based exercise attenuates symptoms of chemotherapy-induced peripheral neuropathy in breast cancer patients. Health Psychol Res 1
15.
Zurück zum Zitat Streckmann F, Lehmann H, Balke M et al (2018) Sensorimotor training and whole-body vibration training have the potential to reduce motor and sensory symptoms of chemotherapy-induced peripheral neuropathy—a randomized controlled pilot trial. Support Care Cancer:1–8 Streckmann F, Lehmann H, Balke M et al (2018) Sensorimotor training and whole-body vibration training have the potential to reduce motor and sensory symptoms of chemotherapy-induced peripheral neuropathy—a randomized controlled pilot trial. Support Care Cancer:1–8
16.
Zurück zum Zitat McCrary JM, Goldstein D, Boyle F et al (2017) Optimal clinical assessment strategies for chemotherapy-induced peripheral neuropathy (CIPN): a systematic review and Delphi survey. Support Care Cancer:1–9 McCrary JM, Goldstein D, Boyle F et al (2017) Optimal clinical assessment strategies for chemotherapy-induced peripheral neuropathy (CIPN): a systematic review and Delphi survey. Support Care Cancer:1–9
17.
Zurück zum Zitat Alberti P, Rossi E, Cornblath D et al (2013) Physician-assessed and patient-reported outcome measures in chemotherapy-induced sensory peripheral neurotoxicity: two sides of the same coin. Ann Oncol 25:257–264CrossRefPubMedPubMedCentral Alberti P, Rossi E, Cornblath D et al (2013) Physician-assessed and patient-reported outcome measures in chemotherapy-induced sensory peripheral neurotoxicity: two sides of the same coin. Ann Oncol 25:257–264CrossRefPubMedPubMedCentral
18.
Zurück zum Zitat Borg GA (1982) Psychophysical bases of perceived exertion. Med Sci Sports Exerc 14:377-381 Borg GA (1982) Psychophysical bases of perceived exertion. Med Sci Sports Exerc 14:377-381
19.
Zurück zum Zitat Schmitz KH, Courneya KS, Matthews C, Demark-Wahnefried W, Galvão DA, Pinto BM, Irwin ML, Wolin KY, Segal RJ, Lucia A, Schneider CM, von Gruenigen VE, Schwartz AL (2010) American College of Sports Medicine roundtable on exercise guidelines for cancer survivors. Med Sci Sports Exerc 42:1409–1426CrossRef Schmitz KH, Courneya KS, Matthews C, Demark-Wahnefried W, Galvão DA, Pinto BM, Irwin ML, Wolin KY, Segal RJ, Lucia A, Schneider CM, von Gruenigen VE, Schwartz AL (2010) American College of Sports Medicine roundtable on exercise guidelines for cancer survivors. Med Sci Sports Exerc 42:1409–1426CrossRef
20.
Zurück zum Zitat Garnacho-Castaño MV, Domínguez R, González AM et al (2018) Exercise prescription using the Borg rating of perceived exertion to improve fitness. Int J Sports Med 39:115–123CrossRefPubMed Garnacho-Castaño MV, Domínguez R, González AM et al (2018) Exercise prescription using the Borg rating of perceived exertion to improve fitness. Int J Sports Med 39:115–123CrossRefPubMed
21.
Zurück zum Zitat Scherr J, Wolfarth B, Christle JW, Pressler A, Wagenpfeil S, Halle M (2013) Associations between Borg’s rating of perceived exertion and physiological measures of exercise intensity. Eur J Appl Physiol 113:147–155CrossRefPubMed Scherr J, Wolfarth B, Christle JW, Pressler A, Wagenpfeil S, Halle M (2013) Associations between Borg’s rating of perceived exertion and physiological measures of exercise intensity. Eur J Appl Physiol 113:147–155CrossRefPubMed
22.
Zurück zum Zitat Cornblath D, Chaudhry V, Carter K et al (1999) Total neuropathy score validation and reliability study. Neurology 53:1660–1660CrossRefPubMed Cornblath D, Chaudhry V, Carter K et al (1999) Total neuropathy score validation and reliability study. Neurology 53:1660–1660CrossRefPubMed
23.
Zurück zum Zitat Postma T, Aaronson N, Heimans J, Muller MJ, Hildebrand JG, Delattre JY, Hoang-Xuan K, Lantéri-Minet M, Grant R, Huddart R, Moynihan C, Maher J, Lucey R, EORTC Quality of Life Group (2005) The development of an EORTC quality of life questionnaire to assess chemotherapy-induced peripheral neuropathy: the QLQ-CIPN20. Eur J Cancer 41:1135–1139CrossRefPubMed Postma T, Aaronson N, Heimans J, Muller MJ, Hildebrand JG, Delattre JY, Hoang-Xuan K, Lantéri-Minet M, Grant R, Huddart R, Moynihan C, Maher J, Lucey R, EORTC Quality of Life Group (2005) The development of an EORTC quality of life questionnaire to assess chemotherapy-induced peripheral neuropathy: the QLQ-CIPN20. Eur J Cancer 41:1135–1139CrossRefPubMed
24.
Zurück zum Zitat Mueller MJ, Tuttle LJ, LeMaster JW et al (2013) Weight-bearing versus nonweight-bearing exercise for persons with diabetes and peripheral neuropathy: a randomized controlled trial. Arch Phys Med Rehabil 94:829–838CrossRef Mueller MJ, Tuttle LJ, LeMaster JW et al (2013) Weight-bearing versus nonweight-bearing exercise for persons with diabetes and peripheral neuropathy: a randomized controlled trial. Arch Phys Med Rehabil 94:829–838CrossRef
25.
26.
Zurück zum Zitat Whitney SL, Wrisley DM, Marchetti GF, Gee MA, Redfern MS, Furman JM (2005) Clinical measurement of sit-to-stand performance in people with balance disorders: validity of data for the five-times-sit-to-stand test. Phys Ther 85:1034–1045PubMed Whitney SL, Wrisley DM, Marchetti GF, Gee MA, Redfern MS, Furman JM (2005) Clinical measurement of sit-to-stand performance in people with balance disorders: validity of data for the five-times-sit-to-stand test. Phys Ther 85:1034–1045PubMed
27.
Zurück zum Zitat Binda D, Vanhoutte E, Cavaletti G, Cornblath DR, Postma TJ, Frigeni B, Alberti P, Bruna J, Velasco R, Argyriou AA, Kalofonos HP, Psimaras D, Ricard D, Pace A, Galiè E, Briani C, Dalla Torre C, Lalisang RI, Boogerd W, Brandsma D, Koeppen S, Hense J, Storey D, Kerrigan S, Schenone A, Fabbri S, Rossi E, Valsecchi MG, Faber CG, Merkies IS, CI-PeriNomS study group, Galimberti S, Lanzani F, Mattavelli L, Piatti ML, Bidoli P, Cazzaniga M, Cortinovis D, Lucchetta M, Campagnolo M, Bakkers M, Brouwer B, Boogerd W, Grant R, Reni L, Piras B, Pessino A, Padua L, Granata G, Leandri M, Ghignotti I, Plasmati R, Pastorelli F, Heimans JJ, Eurelings M, Meijer RJ, Grisold W, Lindeck Pozza E, Mazzeo A, Toscano A, Russo M, Tomasello C, Altavilla G, Penas Prado M, Dominguez Gonzalez C, Dorsey SG (2013) Rasch-built overall disability scale for patients with chemotherapy-induced peripheral neuropathy (CIPN-R-ODS). Eur J Cancer 49:2910–2918CrossRefPubMed Binda D, Vanhoutte E, Cavaletti G, Cornblath DR, Postma TJ, Frigeni B, Alberti P, Bruna J, Velasco R, Argyriou AA, Kalofonos HP, Psimaras D, Ricard D, Pace A, Galiè E, Briani C, Dalla Torre C, Lalisang RI, Boogerd W, Brandsma D, Koeppen S, Hense J, Storey D, Kerrigan S, Schenone A, Fabbri S, Rossi E, Valsecchi MG, Faber CG, Merkies IS, CI-PeriNomS study group, Galimberti S, Lanzani F, Mattavelli L, Piatti ML, Bidoli P, Cazzaniga M, Cortinovis D, Lucchetta M, Campagnolo M, Bakkers M, Brouwer B, Boogerd W, Grant R, Reni L, Piras B, Pessino A, Padua L, Granata G, Leandri M, Ghignotti I, Plasmati R, Pastorelli F, Heimans JJ, Eurelings M, Meijer RJ, Grisold W, Lindeck Pozza E, Mazzeo A, Toscano A, Russo M, Tomasello C, Altavilla G, Penas Prado M, Dominguez Gonzalez C, Dorsey SG (2013) Rasch-built overall disability scale for patients with chemotherapy-induced peripheral neuropathy (CIPN-R-ODS). Eur J Cancer 49:2910–2918CrossRefPubMed
28.
Zurück zum Zitat Ware JE Jr, Sherbourne CD (1992) The MOS 36-item short-form health survey (SF-36): I. Conceptual framework and item selection. Med Care:473–483 Ware JE Jr, Sherbourne CD (1992) The MOS 36-item short-form health survey (SF-36): I. Conceptual framework and item selection. Med Care:473–483
29.
Zurück zum Zitat Kimura J (1983) Electrodiagnosis in diseases of nerve and muscle. F.A. Davis, Philadelphia Kimura J (1983) Electrodiagnosis in diseases of nerve and muscle. F.A. Davis, Philadelphia
30.
Zurück zum Zitat Park SB, Goldstein D, Lin CS-Y, Krishnan AV, Friedlander ML, Kiernan MC (2009) Acute abnormalities of sensory nerve function associated with oxaliplatin-induced neurotoxicity. J Clin Oncol 27:1243–1249CrossRefPubMed Park SB, Goldstein D, Lin CS-Y, Krishnan AV, Friedlander ML, Kiernan MC (2009) Acute abnormalities of sensory nerve function associated with oxaliplatin-induced neurotoxicity. J Clin Oncol 27:1243–1249CrossRefPubMed
31.
Zurück zum Zitat Kiernan MC, Burke D, Andersen KV, Bostock H (2000) Multiple measures of axonal excitability: a new approach in clinical testing. Muscle Nerve 23:399–409CrossRefPubMed Kiernan MC, Burke D, Andersen KV, Bostock H (2000) Multiple measures of axonal excitability: a new approach in clinical testing. Muscle Nerve 23:399–409CrossRefPubMed
32.
Zurück zum Zitat Pachman DR, Qin R, Seisler D, Smith EML, Kaggal S, Novotny P, Ruddy KJ, Lafky JM, Ta LE, Beutler AS, Wagner-Johnston ND, Staff NP, Grothey A, Dougherty PM, Cavaletti G, Loprinzi CL (2016) Comparison of oxaliplatin and paclitaxel-induced neuropathy (Alliance A151505). Support Care Cancer 24:5059–5068CrossRefPubMedPubMedCentral Pachman DR, Qin R, Seisler D, Smith EML, Kaggal S, Novotny P, Ruddy KJ, Lafky JM, Ta LE, Beutler AS, Wagner-Johnston ND, Staff NP, Grothey A, Dougherty PM, Cavaletti G, Loprinzi CL (2016) Comparison of oxaliplatin and paclitaxel-induced neuropathy (Alliance A151505). Support Care Cancer 24:5059–5068CrossRefPubMedPubMedCentral
33.
34.
Zurück zum Zitat Gewandter JS, Brell J, Cavaletti G, Dougherty PM, Evans S, Howie L, McDermott MP, O'Mara A, Smith AG, Dastros-Pitei D, Gauthier LR, Haroutounian S, Jarpe M, Katz NP, Loprinzi C, Richardson P, Lavoie-Smith EM, Wen PY, Turk DC, Dworkin RH, Freeman R (2018) Trial designs for chemotherapy-induced peripheral neuropathy prevention: ACTTION recommendations. Neurology 91:403–413. https://doi.org/10.1212/WNL.0000000000006083 CrossRefPubMedPubMedCentral Gewandter JS, Brell J, Cavaletti G, Dougherty PM, Evans S, Howie L, McDermott MP, O'Mara A, Smith AG, Dastros-Pitei D, Gauthier LR, Haroutounian S, Jarpe M, Katz NP, Loprinzi C, Richardson P, Lavoie-Smith EM, Wen PY, Turk DC, Dworkin RH, Freeman R (2018) Trial designs for chemotherapy-induced peripheral neuropathy prevention: ACTTION recommendations. Neurology 91:403–413. https://​doi.​org/​10.​1212/​WNL.​0000000000006083​ CrossRefPubMedPubMedCentral
35.
Zurück zum Zitat Kluding PM, Pasnoor M, Singh R, Jernigan S, Farmer K, Rucker J, Sharma NK, Wright DE (2012) The effect of exercise on neuropathic symptoms, nerve function, and cutaneous innervation in people with diabetic peripheral neuropathy. J Diabetes Complicat 26:424–429CrossRefPubMedPubMedCentral Kluding PM, Pasnoor M, Singh R, Jernigan S, Farmer K, Rucker J, Sharma NK, Wright DE (2012) The effect of exercise on neuropathic symptoms, nerve function, and cutaneous innervation in people with diabetic peripheral neuropathy. J Diabetes Complicat 26:424–429CrossRefPubMedPubMedCentral
36.
Zurück zum Zitat Sabatier MJ, Redmon N, Schwartz G, English AW (2008) Treadmill training promotes axon regeneration in injured peripheral nerves. Exp Neurol 211:489–493CrossRefPubMedPubMedCentral Sabatier MJ, Redmon N, Schwartz G, English AW (2008) Treadmill training promotes axon regeneration in injured peripheral nerves. Exp Neurol 211:489–493CrossRefPubMedPubMedCentral
37.
Zurück zum Zitat Taube W, Gruber M, Gollhofer A (2008) Spinal and supraspinal adaptations associated with balance training and their functional relevance. Acta Physiol 193:101–116CrossRef Taube W, Gruber M, Gollhofer A (2008) Spinal and supraspinal adaptations associated with balance training and their functional relevance. Acta Physiol 193:101–116CrossRef
38.
Zurück zum Zitat Granacher U, Gollhofer A, Strass D (2006) Training induced adaptations in characteristics of postural reflexes in elderly men. Gait & Posture 24:459–466CrossRef Granacher U, Gollhofer A, Strass D (2006) Training induced adaptations in characteristics of postural reflexes in elderly men. Gait & Posture 24:459–466CrossRef
39.
Zurück zum Zitat Williams RM, Corvo MA, Lam KC et al (2017) Test-retest reliability and practice effects of the stability evaluation test. J Sport Rehabil:1–13 Williams RM, Corvo MA, Lam KC et al (2017) Test-retest reliability and practice effects of the stability evaluation test. J Sport Rehabil:1–13
40.
Zurück zum Zitat Maurer C, Mergner T, Peterka R (2006) Multisensory control of human upright stance. Exp Brain Res 171:231–250CrossRefPubMed Maurer C, Mergner T, Peterka R (2006) Multisensory control of human upright stance. Exp Brain Res 171:231–250CrossRefPubMed
41.
Zurück zum Zitat Greenlee H, Hershman DL, Shi Z et al. BMI, lifestyle factors and taxane-induced neuropathy in breast cancer patients: the pathways study. JNCI: J Natl Cancer Inst 2017; 109 Greenlee H, Hershman DL, Shi Z et al. BMI, lifestyle factors and taxane-induced neuropathy in breast cancer patients: the pathways study. JNCI: J Natl Cancer Inst 2017; 109
42.
Zurück zum Zitat Lord SR, Clark RD, Webster IW (1991) Physiological factors associated with falls in an elderly population. J Am Geriatr Soc 39:1194–1200CrossRefPubMed Lord SR, Clark RD, Webster IW (1991) Physiological factors associated with falls in an elderly population. J Am Geriatr Soc 39:1194–1200CrossRefPubMed
43.
Zurück zum Zitat Angst F, Aeschlimann A, Stucki G (2001) Smallest detectable and minimal clinically important differences of rehabilitation intervention with their implications for required sample sizes using WOMAC and SF-36 quality of life measurement instruments in patients with osteoarthritis of the lower extremities. Arthritis Care Res 45:384–391CrossRef Angst F, Aeschlimann A, Stucki G (2001) Smallest detectable and minimal clinically important differences of rehabilitation intervention with their implications for required sample sizes using WOMAC and SF-36 quality of life measurement instruments in patients with osteoarthritis of the lower extremities. Arthritis Care Res 45:384–391CrossRef
44.
Zurück zum Zitat Goldberg A, Chavis M, Watkins J, Wilson T (2012) The five-times-sit-to-stand test: validity, reliability and detectable change in older females. Aging Clin Exp Res 24:339–344CrossRefPubMed Goldberg A, Chavis M, Watkins J, Wilson T (2012) The five-times-sit-to-stand test: validity, reliability and detectable change in older females. Aging Clin Exp Res 24:339–344CrossRefPubMed
45.
Zurück zum Zitat Perera S, Mody SH, Woodman RC, Studenski SA (2006) Meaningful change and responsiveness in common physical performance measures in older adults. J Am Geriatr Soc 54:743–749CrossRefPubMed Perera S, Mody SH, Woodman RC, Studenski SA (2006) Meaningful change and responsiveness in common physical performance measures in older adults. J Am Geriatr Soc 54:743–749CrossRefPubMed
46.
Zurück zum Zitat Cormie P, Atkinson M, Bucci L, Cust A, Eakin E, Hayes S, McCarthy S, Murnane A, Patchell S, Adams D (2018) Clinical Oncology Society of Australia position statement on exercise in cancer care. Med J Aust 209:184–187CrossRef Cormie P, Atkinson M, Bucci L, Cust A, Eakin E, Hayes S, McCarthy S, Murnane A, Patchell S, Adams D (2018) Clinical Oncology Society of Australia position statement on exercise in cancer care. Med J Aust 209:184–187CrossRef
Metadaten
Titel
Exercise-based rehabilitation for cancer survivors with chemotherapy-induced peripheral neuropathy
verfasst von
J. Matt McCrary
David Goldstein
Carolina X. Sandler
Benjamin K. Barry
Michael Marthick
Hannah C. Timmins
Tiffany Li
Lisa Horvath
Peter Grimison
Susanna B. Park
Publikationsdatum
12.02.2019
Verlag
Springer Berlin Heidelberg
Erschienen in
Supportive Care in Cancer / Ausgabe 10/2019
Print ISSN: 0941-4355
Elektronische ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-019-04680-w

Weitere Artikel der Ausgabe 10/2019

Supportive Care in Cancer 10/2019 Zur Ausgabe

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.